V. Adámková
-
Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery
Petr Kačer, J. Pirk, V. Lánská, J. A. Hubáček, V. Adámek, T. Červinková, J. Bělohoubek, O. Auzký, V. Adámková
2020, Vol. 66, Issue 4, pp. 148-153 -
Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes
Michal Vrablík, J. A. Hubáček, D. Dlouha, M. Satny, V. Adámková, R. Ceska
2019, Vol. 65, Issue 4, pp. 188-194 -
Tagging rs10811661 Variant at CDKN2A/2B Locus Is Not Associated with Type 2 Diabetes Mellitus in Czech Population
Jaroslav A. Hubáček, T. Neškudla, M. Klementová, V. Adámková, T. Pelikánová
2013, Vol. 59, Issue 4, pp. 168-171 -
Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population
Jaroslav A. Hubáček, V. Staněk, M. Gebauerová, R. Poledne, M. Aschermann, H. Skalická, J. Matoušková, A. Kruger, M. Pěnička, H. Hrabáková, J. Veselka, P. Hájek, V. Lánská, V. Adámková, J. Piťha
2012, Vol. 58, Issue 5, pp. 203-208 -
INSIG2 G-102A Promoter Variant Exhibits Context-Dependent Effect on HDL-Cholesterol Levels but Not on BMI in Caucasians
Jaroslav A. Hubáček, P. Suchánek, V. Lánská, J. Piťha, V. Adámková
2011, Vol. 57, Issue 4, pp. 170-172 -
INSIG2 Promoter Variant, Obesity Markers and Lipid Parameters – No Association in a Large Slavonic Caucasian Population Sample
Jaroslav A. Hubáček, L. Kuthanová, R. Bohuslavová, V. Adámková, V. Lánská, T. Meitinger, A. Pfeufer
2010, Vol. 56, Issue 3, pp. 131-134
The following name might also represent this author:
Věra Adámková
-
CD14 Polymorphism Is Not Associated with SARS-CoV-2 Infection in Central European Population
Jaroslav A. Hubáček, Tom Philipp, Ondřej Májek, Dana Dlouhá, Věra Adámková, Ladislav Dušek
2023, Vol. 69, Issue 5-6, pp. 181-185